Leukoreduction system chambers provide a valuable source of functional monocytes for the monocyte activation test by comparison with internationally validated methods-Reference-Cited by-同舟云学术

Leukoreduction system chambers provide a valuable source of functional monocytes for the monocyte activation test by comparison with internationally validated methods

Published:2016-01 Issue: Volume:428 Page:42-49
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Nordgren Ida Karin

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense;Barreiro;PLoS Genet.,2009

2. Assessment of pyrogenic contaminations with validated human whole-blood assay;Daneshian;Nat. Protoc.,2009

3. dbSNP accession: rs4833095 and rs5743618, (dbSNP Build ID: 143);Database of Single Nucleotide Polymorphisms (dbSNP),2015

4. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay;Dehus;J. Endotoxin Res.,2006

5. Chapter 2.6.14. Bacterial endotoxins. 194;European Pharmacopoeia 8.0,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component Shigella GMMA-Based Vaccines;Microorganisms;2021-06-24

2. Applicability of Monocyte Activation Test for Pyrogen Detection in Succinylated Gelatin Injection;Current Pharmaceutical Analysis;2021-04

3. Characterization of peripheral blood mononuclear cells isolated using two kinds of leukocyte filters;Transfusion Clinique et Biologique;2020-02

4. Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study;Vaccine;2019-06

5. Development and validation of a monocyte activation test for the control/safety testing of an OMV-based meningococcal B vaccine;Vaccine;2019-06